9 Best Biotech Penny Stocks to Buy in 2026
On April 24, Drew Pettit, Citi US equity strategist, joined 'The Exchange' on CNBC to discuss the market fundamentals this year, with a positive outlook for the market as investors look past geopolitical...
Prelude Therapeutics Inc (PRLD)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 10,909,256 | $37,309,656 | 0.74% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 10,123,824 | $34,623,478 | 0.2% | |
| 3. | Kynam Capital Derrick Tang | 1,592,551 | $5,446,524 | +102% | 0.34% |
| 4. | EcoR1 Capital Oleg Nodelman | 947,049 | $3,238,908 | 0.14% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 923,626 | $3,158,801 | +290% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 1,126,126 | $4,999,999.44 | 1,126,126 | 2026-04-21 | Filing | |
| $4.44 | 1,689,189 | $7,499,999.16 | 11,808,945 | 2026-04-21 | Filing | |
| $4.44 | 1,126,126 | $4,999,999.44 | 1,126,126 | 2026-04-21 | Filing | |
| $4.44 | 1,689,189 | $7,499,999.16 | 11,808,945 | 2026-04-21 | Filing | |
| $0.69 | 100,000 | $69,250.00 | 480,123 | 2025-03-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.12 | 13,280 | $81,273.60 | 24,220 | 2023-04-06 | Filing | |
| $13.00 | 28,751 | $373,763.00 | 444 | 2021-12-15 | Filing | |
| $16.43 | 400 | $6,570.00 | 444 | 2021-11-16 | Filing | |
| $15.87 | 28,351 | $449,961.56 | 844 | 2021-11-16 | Filing | |
| $32.06 | 1,289 | $41,330.11 | 0 | 2021-10-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,230,406 | $4,207,989 | 0% | |
| 2. | 322,161 | $1,101,790 | 0% | |
| 3. | 321,886 | $1,100,850 | 0% | |
| 4. | 302,458 | $1,034,847 | 0% | |
| 5. | 267,788 | $915,835 | 0% |
News See All
Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript
Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript November 12, 2025Prelude Therapeutics Incorporated beats earnings expectations.
10 Healthcare Stocks with Insider Buying
Investors were processing inflation report on August 10 to find clues on the Federal Reserve’s possible moves. CPI’s growth in July was identical to that of June’s.
Insider Buying Alert: These 10 Stocks are Seeing Significant Insider Activity
In this article, we will take a look at the 10 stocks that are seeing significant buy-side insider activity.
Top 5 Stock Picks of Samuel Isaly's OrbiMed Advisors
In this article, we will discuss the top 5 stock picks of Samuel Isaly's OrbiMed Advisors.
15 Best Short Squeeze Stocks To Buy Now
The retail investor frenzy at the stock market and the short squeeze saga involving GameStop Corp. (NYSE: GME) and AMC Entertainment Holdings, Inc.
Is PRLD A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth ...
Hedge Fund Resource Center